Explore Stanford technologies available for licensing:

Stanford inventors have created a novel, interactive, highly scalable computational approach for representing dynamic brain activity as a network for use in clinical settings.

Stanford inventors have developed an information theoretic, seizure detection algorithm for electroencephalography (EEG) towards improving diagnosis, management, and treatment of patients with epilepsy.

Researchers at Stanford have invented a novel hydrogel with enhanced retention and extended durability. This hydrogel can be held together three times longer than many alternatives without sacrificing its self-healing attributes during injection.

Stanford researchers have developed two novel, minimally invasive neochordal devices for mitral valve repair.

Researchers at Stanford have developed a novel cell-free stem cell derived extracellular vesicle (EV) therapy powered by pulsed focused ultrasound (pFUS) that enhances its therapeutic and bioenergetic effect.

Stanford scientists have invented a new suite of adaptable hydrogel biomaterials that are optically transparent and injectable for cell encapsulation, tissue engineering, and drug delivery.

The Hu Lab at Stanford has identified several FDA-approved small molecule medicines with neuroprotective effects on glaucoma.

Researchers at Stanford have developed a methodology for deep learning-based image reconstruction by incorporating the physics or geometry priors of the imaging system with deep neural networks.

Stanford researchers have developed a new controllable methodology for molecularly targeted ultrasound contrast agent production with pre-formed ligand-phospholipid bioconjugates.

Stanford researchers have designed a new 3-dimensional (3D) hydrogel cell culture system that models native tissue environment with precise control over gelation and degradation properties.

Stanford researchers at the Zhao Lab have developed a wireless, magnetically actuated amphibious origami millirobot that can locomote in narrow spaces and morph their shapes. The researchers have demonstrated that this millirobot can travel on surfaces and through liquid.

Stanford researchers have developed a next-generation computational algorithm for diagnostic of pulmonary hypertension (PH) that provides an estimate of the tricuspid regurgitation (TR) velocity (V_max) with increased accuracy and confidence.

Stanford researchers from the Khuri-Yakub group have designed an improved, high spatial resolution ultrasonic neuromodulation device that implements chip waveform instead of continuous wave PIRF.

Stanford scientists developed Cardiac Conduction System (CCS) targeting monoclonal antibodies.